No Data
Zhongxing Bacteria: Report for the third quarter of 2024
tianshui zhongxing bio-technology (002772.SZ) released the performance for the first three quarters, with net income of 88.65 million yuan, a year-on-year decrease of 49.49%.
Tianshui Zhongxing Bio-Technology (002772.SZ) disclosed its third quarter report for 2024, achieving revenue of 14...
tianshui zhongxing bio-technology (002772.SZ): net income in the first three quarters was 88.6507 million yuan, a year-on-year decrease of 49.49%.
On October 25, GeLongHui reported that Tianshui Zhongxing Bio-Technology (002772.SZ) released its third-quarter report. In the first three quarters of 2024, the company achieved revenue of 1.416 billion yuan, a decrease of 2.48% year-on-year; net income attributable to shareholders of the listed company was 88.6507 million yuan, a decrease of 49.49% year-on-year; net income after deducting non-recurring gains and losses was 65.4606 million yuan, a decrease of 58.47% year-on-year; basic earnings per share were 0.2254 yuan per share.
Express News | Tianshui Zhongxing Bio-Technology: Subsidiary plans to invest 50 million yuan to establish a new company to implement the Cordyceps project.
tianshui zhongxing bio-technology (002772.SZ): Currently, the company's products such as needle mushroom, shimeji mushroom, and beichong grass are all sold as fresh products.
Gelonghui October 14th | tianshui zhongxing bio-technology (002772.SZ) stated on the investor interaction platform that the winter cordyceps industrial production project implemented by Tianjin Jinxing Bio-technology Co., Ltd., a joint venture of the company, has gradually been listed for sale, but the project scale is small and the company's wholly-owned subsidiary Zhongan Bio-technology holds 51% of its equity, so the short-term impact on the company is relatively small. Currently, the company's products like enoki mushrooms, shiitake mushrooms, and northern cordyceps are all sold as fresh products.
Tianshui Zhongxing Bio-technology: Summary of Half-Year Report in 2024.
No Data
No Data